TY -的T1 - fo全球肺倡议方程r pulmonary hypertension screening in systemic sclerosis JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.00528-2018 VL - 52 IS - 3 SP - 1800528 AU - Soumagne, Thibaud AU - Guillien, Alicia AU - Chambellan, Arnaud AU - Hua-Huy, Thông AU - Dinh-Xuan, Anh Tuan AU - Degano, Bruno Y1 - 2018/09/01 UR - //www.qdcxjkg.com/content/52/3/1800528.abstract N2 - Systemic sclerosis (SSc) is a connective tissue disease characterised by widespread vasculopathy and excessive fibrosis in multiple organs, including the lungs [1]. The most frequent pulmonary involvement in SSc is interstitial lung disease (ILD), but the most harmful is pulmonary hypertension (PH), a complication found in about 10% of SSc patients [2]. In patients with SSc, early diagnosis of and prompt therapy for PH (either isolated or associated with ILD) are beneficial from a prognostic standpoint and recommendations for active screening of PH in SSc have therefore been established [3].GLI equations provide new cut-offs for TLCO for detection of PH in patients with SSc, either with or without ILD http://ow.ly/aCpD30l2zch ER -